{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T14:56:41Z","timestamp":1791385001259,"version":"4.3.3"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006668","name":"Oregon Health and Science University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006668","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 EY010572"],"award-info":[{"award-number":["P30 EY010572"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ajo.2025.10.021","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:26:57Z","timestamp":1761089217000},"page":"666-673","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Glucagon-like Peptide-1 Receptor Agonist Use and Risk of Cataract Development"],"prefix":"10.1016","volume":"281","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4333-9189","authenticated-orcid":false,"given":"ABHIMANYU S.","family":"AHUJA","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"ALFREDO A.","family":"PAREDES","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SEJAL A.","family":"AHUJA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BENJAMIN K.","family":"YOUNG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10374","key":"10.1016\/j.ajo.2025.10.021_bib0001","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0140-6736(22)01839-6","article-title":"Cataracts","volume":"401","author":"Cicinelli","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.ajo.2025.10.021_bib0002","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.diabres.2018.12.001","article-title":"The association between diabetes and cataract among 42,469 community-dwelling adults in six low- and middle-income countries","volume":"147","author":"Pizzol","year":"2019","journal-title":"Diabetes Res Clin Pract"},{"issue":"5","key":"10.1016\/j.ajo.2025.10.021_bib0003","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/OPX.0000000000000243","article-title":"Overweight, obesity, and age-related cataract: a meta-analysis","volume":"91","author":"Pan","year":"2014","journal-title":"Optom Vis Sci"},{"key":"10.1016\/j.ajo.2025.10.021_bib0004","article-title":"Association between obesity and age-related cataract: an updated systematic review and dose-response meta-analysis of prospective cohort studies","volume":"10","author":"Niazi","year":"2023","journal-title":"Front Nutr"},{"issue":"1","key":"10.1016\/j.ajo.2025.10.021_bib0005","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/s41598-024-84204-7","article-title":"Association between systemic immune inflammation index and cataract incidence from 2005 to 2008","volume":"15","author":"Li","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajo.2025.10.021_bib0006","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.cytogfr.2018.10.002","article-title":"Pro-inflammatory cytokines: the link between obesity and osteoarthritis","volume":"44","author":"Wang","year":"2018","journal-title":"Cytokine Growth Factor Rev"},{"issue":"7","key":"10.1016\/j.ajo.2025.10.021_bib0007","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1586\/14779072.2015.1054810","article-title":"Liraglutide for Type 2 diabetes and obesity: a 2015 update","volume":"13","author":"Iepsen","year":"2015","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"3","key":"10.1016\/j.ajo.2025.10.021_bib0008","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.tcm.2021.12.008","article-title":"Semaglutide for the treatment of obesity","volume":"33","author":"Chao","year":"2023","journal-title":"Trends Cardiovasc Med"},{"issue":"11","key":"10.1016\/j.ajo.2025.10.021_bib0009","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ajo.2025.10.021_bib0010","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.japh.2023.10.002","article-title":"Trends in glucagon-like peptide 1 receptor agonist use, 2014 to 2022","volume":"64","author":"Watanabe","year":"2024","journal-title":"J Am Pharm Assoc (2003)"},{"key":"10.1016\/j.ajo.2025.10.021_bib0011","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1516126","article-title":"A comprehensive review of methodologies and application to use the real-world data and analytics platform TriNetX","volume":"16","author":"Ludwig","year":"2025","journal-title":"Front Pharmacol"},{"issue":"5","key":"10.1016\/j.ajo.2025.10.021_bib0012","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.20f13681","article-title":"Mean difference, standardized mean difference (SMD), and their use in meta-analysis: as simple as it gets","volume":"81","author":"Andrade","year":"2020","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"10.1016\/j.ajo.2025.10.021_bib0013","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.50050","article-title":"Sodium-glucose cotransport protein 2 inhibitors in patients with type 2 diabetes and acute kidney disease","volume":"7","author":"Pan","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ajo.2025.10.021_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.ophtha.2025.01.016","article-title":"Glucagon-like peptide-1 receptor agonist impact on chronic ocular disease including age-related macular degeneration","author":"Allan","year":"2025","journal-title":"Ophthalmology"},{"issue":"10434","key":"10.1016\/j.ajo.2025.10.021_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(24)00351-9","article-title":"Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials","volume":"403","author":"Shi","year":"2024","journal-title":"Lancet"},{"issue":"22","key":"10.1016\/j.ajo.2025.10.021_bib0016","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1001\/jama.2016.7602","article-title":"Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse Events: a systematic review and meta-analysis","volume":"315","author":"Khera","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.ajo.2025.10.021_bib0017","doi-asserted-by":"crossref","DOI":"10.1177\/20420188231222367","article-title":"Anti-inflammatory role of glucagon-like peptide 1 receptor agonists and its clinical implications","volume":"15","author":"Alharbi","year":"2024","journal-title":"Ther Adv Endocrinol Metab"},{"key":"10.1016\/j.ajo.2025.10.021_bib0018","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1148209","article-title":"Glucagon-like peptide-1: a multi-faceted anti-inflammatory agent","volume":"14","author":"Mehdi","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajo.2025.10.021_bib0019","article-title":"Association between obesity and age-related cataract: an updated systematic review and dose-response meta-analysis of prospective cohort studies","volume":"10","author":"Niazi","year":"2023","journal-title":"Front Nutr"},{"issue":"2","key":"10.1016\/j.ajo.2025.10.021_bib0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0089923","article-title":"Body mass index and risk of age-related cataract: a meta-analysis of prospective cohort studies","volume":"9","author":"Ye","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ajo.2025.10.021_bib0021","unstructured":"U.S. Food and Drug Administration. BELVIQ (Lorcaserin Hydrochloride) Tablets.; 2014. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2014\/022529s003lbl.pdf Accessed September 2, 2025."},{"issue":"8","key":"10.1016\/j.ajo.2025.10.021_bib0022","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1001\/archophthalmol.2010.147","article-title":"Smoking, socioeconomic factors, and age-related cataract: the Singapore Malay Eye study","volume":"128","author":"Wu","year":"2010","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2025.10.021_bib0023","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ajo.2023.03.017","article-title":"The impact of social determinants of health on vision loss from cataracts and cataract surgery utilization in the united states-a national health interview survey analysis","volume":"254","author":"Awidi","year":"2023","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2025.10.021_bib0024","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.jcjo.2013.07.001","article-title":"Relationship between cataract severity and socioeconomic status","volume":"48","author":"Wesolosky","year":"2013","journal-title":"Can J Ophthalmol"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939425005586?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939425005586?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T13:51:19Z","timestamp":1773323479000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939425005586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":24,"alternative-id":["S0002939425005586"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2025.10.021","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glucagon-like Peptide-1 Receptor Agonist Use and Risk of Cataract Development","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2025.10.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}